BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19539569)

  • 1. Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target.
    Zhou Z; Song X; Berezov A; Li B; Greene MI
    Int Immunopharmacol; 2009 May; 9(5):518-20. PubMed ID: 19539569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.
    Sadlon TJ; Wilkinson BG; Pederson S; Brown CY; Bresatz S; Gargett T; Melville EL; Peng K; D'Andrea RJ; Glonek GG; Goodall GJ; Zola H; Shannon MF; Barry SC
    J Immunol; 2010 Jul; 185(2):1071-81. PubMed ID: 20554955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3 is required throughout the life of a regulatory T cell.
    Lopes JE; Soper DM; Ziegler SF
    Sci STKE; 2007 Jul; 2007(393):pe36. PubMed ID: 17609478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
    Ohkura N; Hamaguchi M; Sakaguchi S
    Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trafficking of FoxP3+ regulatory T cells: myths and facts.
    Kim CH
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
    Campbell DJ; Ziegler SF
    Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
    Zheng Y; Josefowicz SZ; Kas A; Chu TT; Gavin MA; Rudensky AY
    Nature; 2007 Feb; 445(7130):936-40. PubMed ID: 17237761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
    Carson BD; Ziegler SF
    Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.
    Li B; Greene MI
    Immunology; 2008 Jan; 123(1):17-9. PubMed ID: 18154614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
    Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
    J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
    Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
    Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box protein 3: essential immune regulatory role.
    Nik Tavakoli N; Hambly BD; Sullivan DR; Bao S
    Int J Biochem Cell Biol; 2008; 40(11):2369-73. PubMed ID: 18037337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3 as a marker of tolerance induction versus rejection.
    Zhang GY; Hu M; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of FOXP3.
    Buckner JH; Ziegler SF
    Ann N Y Acad Sci; 2008 Nov; 1143():151-69. PubMed ID: 19076349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.